Potential anti-neuroinflammatory NF-кB inhibitors based on 3,4-dihydronaphthalen-1(2H)-one derivatives

References

• Cunha MI, Su M, Cantuti-Castelvetri L, et al. Pro-inflammatory activation following demyelination is required for myelin clearance and oligodendrogenesis. J Exp Med 2020;217:e20191390.
   PubMed Web of Science ®Google Scholar
• Goldmann T, Prinz M. Role of microglia in CNS autoimmunity. Clin Dev Immunol 2013;2013:208093.
   PubMedGoogle Scholar
• Streit WJ, Xue QS, Tischer J, et al. Microglial pathology. Acta Neuropathol Commun 2014;2:142.
   PubMed Web of Science ®Google Scholar
• Correale J. The role of microglial activation in disease progression. Mult Scler 2014;20:1288–95.
   PubMed Web of Science ®Google Scholar
• Pisanu A, Lecca D, Mulas G, et al. Dynamic changes in pro- and anti-inflammatory cytokines in microglia after PPAR-γ agonist neuroprotective treatment in the MPTPp mouse model of progressive Parkinson's disease. Neurobiol Dis 2014;71:280–91.
   PubMed Web of Science ®Google Scholar
• Yan AJ, Cai GY, Xia WL, et al. Thromboxane A2 receptor antagonist SQ29548 suppresses the LPS-induced release of inflammatory cytokines in BV2 microglia cells via suppressing MAPK and NF-κB signaling pathways. Mol Med Rep 2017;16:2491–6.
   PubMed Web of Science ®Google Scholar
• Nishioku T, Matsumoto J, Dohgu S, et al. Tumor necrosis factor-alpha mediates the blood-brain barrier dysfunction induced by activated microglia in mouse brain microvascular endothelial cells. J Pharmacol Sci 2010;112:251–4.
   PubMed Web of Science ®Google Scholar
• da Fonseca AC, Matias D, Garcia C, et al. The impact of microglial activation on blood-brain barrier in brain diseases. Front Cell Neurosci 2014;8:362.
   PubMed Web of Science ®Google Scholar
• Hou Y, Ryu CH, Park KY, et al. Effective combination of human bone marrow mesenchymal stem cells and minocycline in experimental autoimmune encephalomyelitis mice. Stem Cell Res Ther 2013;4:77.
   PubMed Web of Science ®Google Scholar
• Yang Y, Salayandia VM, Thompson JF, et al. Attenuation of acute stroke injury in rat brain by minocycline promotes blood-brain barrier remodeling and alternative microglia/macrophage activation during recovery. J Neuroinflammation 2015;12:26.
   PubMed Web of Science ®Google Scholar
• Dai J, Zhang X, Li L, et al. Autophagy inhibition contributes to ROS-producing NLRP3-dependent inflammasome activation and cytokine secretion in high glucose-induced macrophages. Cell Physiol Biochem 2017;43:247–56.
   PubMedGoogle Scholar
• Lee E, Hwang I, Park S, et al. MPTP-driven NLRP3 inflammasome activation in microglia plays a central role in dopaminergic neurodegeneration. Cell Death Differ 2019;26:213–28.
   PubMed Web of Science ®Google Scholar
• Ye Y, Jin T, Zhang X, et al. Meisoindigo protects against focal cerebral ischemia-reperfusion injury by inhibiting NLRP3 inflammasome activation and regulating microglia/macrophage polarization via TLR4/NF-κB signaling pathway. Front Cell Neurosci 2019;13:553.
   PubMed Web of Science ®Google Scholar
• Ślusarczyk J, Trojan E, Głombik K, et al. Targeting the NLRP3 inflammasome-related pathways via tianeptine treatment-suppressed microglia polarization to the M1 phenotype in lipopolysaccharide-stimulated cultures. Int J Mol Sci 2018;19:1965.
   Web of Science ®Google Scholar
• Aryanpour R, Pasbakhsh P, Zibara K, et al. Progesterone therapy induces an M1 to M2 switch in microglia phenotype and suppresses NLRP3 inflammasome in a cuprizone-induced demyelination mouse model. Int Immunopharmacol 2017;51:131–9.
   PubMed Web of Science ®Google Scholar
• Jha S, Srivastava SY, Brickey WJ, et al. The inflammasome sensor, NLRP3, regulates CNS inflammation and demyelination via caspase-1 and interleukin-18. J Neurosci 2010;30:15811–20.
   PubMed Web of Science ®Google Scholar
• Laudisi F, Spreafico R, Evrard M, et al. Cutting edge: The NLRP3 inflammasome links complement-mediated inflammation and IL-1β release. J Immunol 2013;191:1006–10.
   PubMed Web of Science ®Google Scholar
• Zeng KW, Wang S, Dong X, et al. Sesquiterpene dimer (DSF-52) from Artemisia argyi inhibits microglia-mediated neuroinflammation via suppression of NF-κB, JNK/p38 MAPKs and Jak2/Stat3 signaling pathways. Phytomedicine 2014;21:298–306.
   PubMed Web of Science ®Google Scholar
• Barlow JW, Zhang T, Woods O, et al. Novel mast cell-stabilising amine derivatives of 3,4 dihydronaphthalen-1(2H)-one and 6,7,8,9-tetrahydro-5H-benzo[7]annulen-5-one. Med Chem 2011;7:213–23.
   PubMed Web of Science ®Google Scholar
• Kirby AJ, Le LR, Maharlouie F, et al. Inhibition of retinoic acid metabolising enzymes by 2-(4-aminophenylmethyl)-6-hydroxy-3,4-dihydronaphthalen-1(2H)-one and related compounds. J Enzyme Inhib Med Chem 2003;18:27–33.
   PubMed Web of Science ®Google Scholar
• Wang FL, Zhang RX, Cui Y, et al. Design, synthesis and biological evaluation of 3,4-dihydronaphthalen-1(2H)-one derivatives as Bcl-2 inhibitors. Res Chem Intermed 2017;43:5933–42.
   Web of Science ®Google Scholar
• Barlow JW, Walsh JJ. Synthesis and evaluation of 4-amino-3,4-dihydro-2H-naphthalen-1-one derivatives as mast cell stabilising and anti-inflammatory compounds. Eur J Med Chem 2008;43:2891–900.
   PubMed Web of Science ®Google Scholar
• Ding Y, Ko MH, Pehar M, et al. Biochemical inhibition of the acetyltransferases ATase1 and ATase2 reduces β-secretase (BACE1) levels and Aβ generation. J Biol Chem 2012;287:8424–33.
   PubMed Web of Science ®Google Scholar
• Sun Y, Gao ZF, Wang CH, et al. Synthesis, crystal structures and anti-inflammatory activity of fluorine-substituted 1,4,5,6-tetrahydrobenzo[h]quinazolin-2-amine derivatives. Acta Crystallogr C Struct Chem 2019;75:1157–65.
   PubMed Web of Science ®Google Scholar
• Coen DM, Schaffer PA. Antiherpesvirus drugs: a promising spectrum of new drugs and drug targets. Nat Rev Drug Discov 2003;2:278–88.
   PubMed Web of Science ®Google Scholar
• Egan WJ, Lauri G. Prediction of intestinal permeability. Adv Drug Deliver Rev 2002;54:273–89.
   PubMed Web of Science ®Google Scholar
• Singh N, Pandey J, Tripathi RP. A natural aminosugar as organocatalyst for an ecofriendly direct aldol reaction of ketones with aromatic aldehydes in water. Catal Comm 2008;9:743–6.
   Web of Science ®Google Scholar
• Li N, Xin WY, Yao BR, et al. Novel dissymmetric 3,5-bis(arylidene)-4-piperidones as potential antitumor agents with biological evaluation in vitro and in vivo. Eur J Med Chem 2018;147:21–33.
   PubMed Web of Science ®Google Scholar
• Yao BR, Sun Y, Chen SL, et al. Dissymmetric pyridyl-substituted 3,5-bis(arylidene)-4-piperidones as anti-hepatoma agents by inhibiting NF-κB pathway activation. Eur J Med Chem 2019;167:187–99.
   PubMed Web of Science ®Google Scholar
• Li N, Yao BY, Wang CH, et al. Synthesis, crystal structure and activity evaluation of novel 3,4-dihydro-1-benzoxepin-5(2H)-one derivatives as protein-tyrosine kinase (PTK) inhibitors. Acta Crystallogr C Struct Chem 2017;73:1003–9.
   PubMed Web of Science ®Google Scholar
• Jiang CS, Zhuang CL, Zhu K, et al. Identification of a novel small-molecule Keap1-Nrf2 PPI inhibitor with cytoprotective effects on LPS-induced cardiomyopathy. J Enzyme Inhib Med Chem 2018;33:833–41.
   PubMed Web of Science ®Google Scholar
• Gao CL, Hou GG, Liu J, et al. Synthesis and target identification of benzoxepane derivatives as potential anti-neuroinflammatory agents for ischemic stroke. Angew. Chem. Int. Ed. Engl 2020;59:2429–39.
   PubMed Web of Science ®Google Scholar
• Gouverneur V, Müller K. Fluorine in pharmaceutical and medicinal chemistry. 2012.
   Google Scholar
• Zhang LS, Chen Q, Hou GG, et al. Hydroxyl-substituted double Schiff-base condensed 4-piperidone/cyclohexanones as potential anticancer agents with biological evaluation. J Enzyme Inhib Med Chem 2019;34:264–71.
   PubMed Web of Science ®Google Scholar
• Su CM, Hou GG, Wang CH, et al. Potential multifunctional agents with anti-hepatoma and anti-inflammation properties by inhibiting NF-кB activation. J Enzyme Inhib Med Chem 2019;34:1287–97.
   PubMed Web of Science ®Google Scholar
• Hou Y, Fu J, Sun S, et al. BDE-209 induces autophagy and apoptosis via IRE1α/Akt/mTOR signaling pathway in human umbilical vein endothelial cells. Environ Pollut 2019;253:429–38.
   PubMed Web of Science ®Google Scholar
• Stancu IC, Cremers N, Vanrusselt H, et al. Aggregated Tau activates NLRP3-ASC inflammasome exacerbating exogenously seeded and non-exogenously seeded Tau pathology in vivo. Acta Neuropathol 2019;137:599–617.
   PubMed Web of Science ®Google Scholar
• Ozaki E, Campbell M, Doyle SL. Targeting the NLRP3 inflammasome in chronic inflammatory diseases: current perspectives. J Inflamm Res 2015;8:15–27.
   PubMed Web of Science ®Google Scholar
• Xu X, Yin D, Ren H, et al. Selective NLRP3 inflammasome inhibitor reduces neuroinflammation and improves long-term neurological outcomes in a murine model of traumatic brain injury. Neurobiol Dis 2018;117:15–27.
   PubMed Web of Science ®Google Scholar
• Yang HM, Yang S, Huang SS, et al. Microglial activation in the pathogenesis of Huntington’s disease. Front Aging Neurosci 2017;9:193.
   PubMed Web of Science ®Google Scholar